Skip to content

RNA Therapeutics - CORRECT

Nucleic acid-based therapeutics constitute a core therapeutic modality for Evox’s development programs, and we have sophisticated capabilities for the loading of various nucleic acids (primarily RNAs) into exosomes.

RNA loading is done via either proprietary exogenous or endogenous loading methods, enabling Evox to work across both natural and non-natural oligonucleotides. Solving the non-hepatic delivery challenge of nucleic acid-based drugs – such as siRNAs, anti-sense or even gene editing modalities – is a core mission for Evox and tissue-targeted exosomes represent a very promising technology to achieve the delivery of RNA therapeutics.

We use cookies to give you the best experience of using this website. By continuing to use this site, you accept our use of cookies. Please read our Cookie Policy for more information.